154 related articles for article (PubMed ID: 15327734)
1. Factor structure of the CERAD neuropsychological battery.
Strauss ME; Fritsch T
J Int Neuropsychol Soc; 2004 Jul; 10(4):559-65. PubMed ID: 15327734
[TBL] [Abstract][Full Text] [Related]
2. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample.
Jones SN; Ayers CR
Arch Clin Neuropsychol; 2006 May; 21(4):359-65. PubMed ID: 16766158
[TBL] [Abstract][Full Text] [Related]
4. The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample.
Guruje O; Unverzargt FW; Osuntokun BO; Hendrie HC; Baiyewu O; Ogunniyi A; Hali KS
West Afr J Med; 1995; 14(1):29-33. PubMed ID: 7626529
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
[TBL] [Abstract][Full Text] [Related]
6. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia.
Bigler ED; Neeley ES; Miller MJ; Tate DF; Rice SA; Cleavinger H; Wolfson L; Tschanz J; Welsh-Bohmer K
J Int Neuropsychol Soc; 2004 May; 10(3):442-52. PubMed ID: 15147601
[TBL] [Abstract][Full Text] [Related]
7. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
[TBL] [Abstract][Full Text] [Related]
8. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.
Berres M; Monsch AU; Bernasconi F; Thalmann B; Stähelin HB
Stud Health Technol Inform; 2000; 77():195-9. PubMed ID: 11187541
[TBL] [Abstract][Full Text] [Related]
9. Early detection of Alzheimer's disease with a total score of the German CERAD.
Ehrensperger MM; Berres M; Taylor KI; Monsch AU
J Int Neuropsychol Soc; 2010 Sep; 16(5):910-20. PubMed ID: 20682088
[TBL] [Abstract][Full Text] [Related]
10. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
[TBL] [Abstract][Full Text] [Related]
11. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
12. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
14. Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings.
Fillenbaum GG; Beekly D; Edland SD; Hughes JP; Heyman A; van Belle G
Top Health Inf Manage; 1997 Aug; 18(1):47-58. PubMed ID: 10173753
[TBL] [Abstract][Full Text] [Related]
15. [Validity and reliability of the CERAD-Col neuropsychological battery].
Aguirre-Acevedo DC; Gómez RD; Moreno S; Henao-Arboleda E; Motta M; Muñoz C; Arana A; Pineda DA; Lopera F
Rev Neurol; 2007 Dec 1-15; 45(11):655-60. PubMed ID: 18050096
[TBL] [Abstract][Full Text] [Related]
16. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
18. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).
Mistridis P; Egli SC; Iverson GL; Berres M; Willmes K; Welsh-Bohmer KA; Monsch AU
Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):407-17. PubMed ID: 25555899
[TBL] [Abstract][Full Text] [Related]
19. The existence of cognitive plateaus in Alzheimer's disease.
Bozoki AC; An H; Bozoki ES; Little RJ
Alzheimers Dement; 2009 Nov; 5(6):470-8. PubMed ID: 19896586
[TBL] [Abstract][Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
